News | April 01, 2013

Loma Linda’s robotic positioning arm first in U.S. for patient’s use

April 1, 2013 — For more than three decades various forms of robotics have been effectively applied in healthcare to advance different types of medical treatment and surgical processes. Now, the nation’s first robotic positioning arm for proton therapy is being used by Loma Linda University Medical Center (LLUMC) to provide physicians improved access to tumors typically regarded as difficult to reach and treat.

An increasingly attractive alternative to standard photon beam radiation (or IMRT), a proton beam more effectively pinpoints cancerous tumors while minimizing contact with surrounding healthy bone and tissue. The robotic positioning arm at LLUMC’s James M. Slater Proton Treatment and Research Center takes that effectiveness one step further by giving physicians improved access to reach tumors such as those in the liver, breast, prostate and lung.

The user-friendly, computer-controlled robotic arm in use at Loma Linda is the most advanced proton technology found anywhere in the world and combines the flexibility and accuracy needed for optimal treatment of a tumor. The robotic arm decreases the time needed to position a patient for proton treatments and verifies the location and dose of the prescribed treatment based on the patient’s individualized treatment plan. By assuring such accuracy and controlling the movement of the patient during treatment, the hospital is better able to precisely and safely target the tumor in a way that provides the correct therapeutic dose and avoids harm to healthy tissues surrounding the tumor.

“In addition to successfully treating the cancer itself, a patient’s comfort during treatment is of the utmost importance to us,” said Jerry D. Slater, M.D., chairman of the LLUMC center. “Not only does the robotic positioning arm allow proton beams to reach tumors more precisely, it’s also very comfortable for patients and helps alleviate some of the fears that traditionally accompany cancer treatment.”

Based on the expanded reach that the robotic positioning arm allows, physicians at LLUMC are now working on new clinical trials to study the effects of proton treatment on various types of tumors. According to Slater, “Since we have installed the robotic positioning arm, we have launched additional research studies such as our breast cancer trial to more closely examine the effects of treatment on tumors previously considered difficult to reach.”

For more information: www.lomalindahealth.org

Related Content

MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
more healthcare providers and patients are choosing options such as Gamma Knife stereotactic radiosurgery
News | Radiation Therapy | July 31, 2017
Each year, up to 650,000 people who were previously diagnosed with various forms of cancer will develop brain...
Eight Proton Therapy Centers Worldwide Adopt RayStation for Treatment Planning
News | Treatment Planning | July 21, 2017
RaySearch Laboratories reported that eight additional proton therapy centers worldwide have recently chosen RayStation...
IBA to Install Proton Therapy Facility at Inova Schar Cancer Institute
News | Proton Therapy | July 18, 2017
IBA (Ion Beam Applications S.A.) and Inova recently signed a contract for a two-room Proteus Plus proton therapy...
Proton International and Beaumont Health Open Michigan's First Proton Therapy Facility
News | Proton Therapy | July 17, 2017
Proton International (PI) and Beaumont Health recently opened the state’s first proton therapy center, offering the...
ASTRO Updates Insurance Coverage Recommendations for Proton Therapy
News | Proton Therapy | July 17, 2017
The American Society for Radiation Oncology (ASTRO) has issued an update to its recommendations for medical insurance...
Elekta’s MR-linac integrates an advanced linear accelerator and a 1.5T magnetic resonance imaging (MRI) system

Elekta’s MR-linac integrates an advanced linear accelerator and a 1.5T magnetic resonance imaging (MRI) system. Combined, these systems will allow for simultaneous radiation therapy delivery and high-field MR tumor monitoring.

Feature | Radiation Oncology | July 05, 2017 | By Jeff Zagoudis
Image-guided radiation therapy offers great potential to improve the efficiency of treating cancer patients by more...

Photo courtesy of RaySearch

Feature | Treatment Planning | July 05, 2017 | By Jeff Zagoudis
While radiation oncologists have a number of proven techniques at their disposal for treating patients, the reality is...
IBA and Philips Step Up Commercial Collaboration in Brazilian Proton Therapy Market
News | Radiation Therapy | July 03, 2017
IBA and Philips announced in mid-June they are stepping up their combined effort for proton therapy in Brazil.
Overlay Init